Aptose Biosciences Inc [NASDAQ: APTO] traded at a low on Monday, posting a -10.82 loss after which it closed the day’ session at $0.25.
The results of the trading session contributed to over 8081826 shares changing hands. Over the past one week, the price volatility of Aptose Biosciences Inc stands at 24.00% while the volatility over the past one month is 15.00%.
The market cap for APTO stock reached $14.81 million, with 59.52 million shares outstanding and 55.85 million shares in the current float. Compared to the average trading volume of 6.04M shares, APTO reached a trading volume of 8081826 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Aptose Biosciences Inc [APTO]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APTO shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APTO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Aptose Biosciences Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on October 19, 2020. While these analysts kept the previous recommendation, Alliance Global Partners raised their target price to Buy. The new note on the price target was released on September 22, 2020, representing the official price target for Aptose Biosciences Inc stock. Previously, the target price had yet another raise to $16, while Maxim Group analysts kept a Buy rating on APTO stock. On February 06, 2020, analysts increased their price target for APTO shares from 6 to 9.
How has APTO stock performed recently?
Aptose Biosciences Inc [APTO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 31.50. With this latest performance, APTO shares gained by 1.97% in over the last four-week period, additionally sinking by -66.38% over the last 6 months – not to mention a drop of -88.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APTO stock in for the last two-week period is set at 53.21, with the RSI for the last a single of trading hit 60.13, and the three-weeks RSI is set at 48.34 for Aptose Biosciences Inc [APTO]. The present Moving Average for the last 50 days of trading for this stock 0.2971, while it was recorded at 0.2129 for the last single week of trading, and 0.7166 for the last 200 days.
Aptose Biosciences Inc [APTO]: Deeper insight into the fundamentals
Aptose Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.05 and a Current Ratio set at 1.05.
Insider trade positions for Aptose Biosciences Inc [APTO]
There are presently around $16.68%, or 19.96%% of APTO stock, in the hands of institutional investors.
